HXN-2006

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameHXN-2006
Drug Alias NameHXN-2006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor-associated calcium signal transducer 2 modulatorsProgrammed death-ligand 1 modulators
TargetsTumor-associated calcium signal transducer 2Programmed death-ligand 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesEarendil Labs
China Registration ClassN/A

Develop Information

Active CompaniesEarendil Labs
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A